OPTICLOX EYE OINTMENT

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

CLOXACILLIN AS THE BENZATHINE SALT

Available from:

NORBROOK LABORATORIES AUSTRALIA PTY LIMITED

INN (International Name):

cloxacillin as benzathine(833mg/Sg)

Pharmaceutical form:

MISC. AURAL, OPHTHALMIC, ORO/NASO PHARYNGEAL

Composition:

CLOXACILLIN AS THE BENZATHINE SALT ANTIBIOTIC Active 833.0 mg/Sg

Units in package:

%20x5g; (syringes); 5g Syringe

Class:

VM - Veterinary Medicine

Therapeutic group:

CAT | CATTLE | DOG | HORSE | SHEEP | BEEF | BITCH | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | CASTRA

Therapeutic area:

OPHTHALMIC PREPARATIONS

Therapeutic indications:

BACTERIAL KERATO CONJUNCTIVITIS

Product summary:

Poison schedule: 4; Withholding period: WHP: NIL; Host/pest details: CAT: [BACTERIAL KERATO CONJUNCTIVITIS]; CATTLE: [BACTERIAL KERATO CONJUNCTIVITIS]; DOG: [BACTERIAL KERATO CONJUNCTIVITIS]; HORSE: [BACTERIAL KERATO CONJUNCTIVITIS]; SHEEP: [BACTERIAL KERATO CONJUNCTIVITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [BACTERIAL KERATO CONJUNCTIVITIS]; CATTLE: [BACTERIAL KERATO CONJUNCTIVITIS]; DOG: [BACTERIAL KERATO CONJUNCTIVITIS]; HORSE: [BACTERIAL KERATO CONJUNCTIVITIS]; SHEEP: [BACTERIAL KERATO CONJUNCTIVITIS]; For the treatment of bovine keratoconjunctivitis caused by cloxacillin-susceptible bacteria including Moraxella bovis. Also for the treatment of bacterial keratoconjunctivitis caused by cloxacillin-susceptible bacteria in sheep, horses, dogs and cats.Do not administer to animals with a history of allergic reaction to penicillins. People allergic to penicillins should wear gloves when administering the treatment. Other Warnings, etc: See Label.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

"Sl8:J
pue
S6op
'SaSJ04
'daa4S
Uj epa!::>Bq 9jq!lda::>SnS-U!Il!:lBXOj:J
"SJIIDq fl/lfJX
fJ.JOVO/
6Ujpnj:JU! B!J9!:JBq 9jq!!d9::>SnS-UII!!:lBXOj:J
Aq p9Sne::> S!!!fl!!::>un[uo::>OlBJ9)j
IB!J9!::>Bq
~o
lU9WlB9J!
84l
Jo~
OS!If
Aq
p9sne:J
S!U.fi!PUn[uo::>OlBJ9)j
9Ujfloq
~o
lU9WlB9Jl
84l
JO
.:J
·taes
au!tnezuaq
se
unn:)eXOIO
6w
££8
:a6U!J.1
A0311\13H
1YII\II
NY
NOI.Ld IHOS3Hd
PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF REACH OF CHILDREN
FORANIMAL
TREATMENTONLY
OpticloxrM Eye
Ointment
Active
Constituent
per
5g
syringe:
833
mg
Cloxaci
llin
as
benzathine
salt
For
the treatment of bovine keratoconjunctivitis caused
by
cloxacillin-susceptible bacteria including
Moraxel/a bovis.
Also for the treatment of bacterial keratoconjunctivitis caused
by
cloxacillin-susceptible bacteria
in
sheep, horses, dogs
and
cats.
· ,
Norbrooli
~
20
Syringes Each 5 g
READ
ENCLOSED
LEAFLET
BEFORE
USING THIS
PRODUCT
DIRECTIONS
FOR
USE
Contraindication&:
This product is contrai
nd
icated for use
in
animals with
a history of allergic reactions to penicillins.
Precautions:
Peop
le allergic
to
penicillins should wear
gloves when administeri
ng
the treatment
Dosage and Administration:
For t
op
ical use only.
Instil liberally into lower conjunctival sac of affected
animals.
Cattle, Sheep and Horses:
15%
to
30%
of the contents
of
one
sy
ringe per
eye.
Treatment may
be
repeated at
48-hour intervals if required.
Dogs and Cats:
Instil liberally into both eyes
on
a daily
basis.
If
the
animal has
on
ly one eye Infected,
It
Is advisable
to
treat
both
eyes
to
prevent
cross
Infection.
In
such
cases
treat
the
unlnfected eye
first
to
avoid
tran
sf
erring the Infection via
the
syringe.
OPTIC
L
OX
Eye
Ointment
is
effecti
ve
against a range of
bacteria commonly isolated from the
eyes
of cattle,
sheep, horses, dogs
and
cats.
It
is bactericidal
in
action
and
its formulation facilitates persistence of cloxacillin
levels for at least
48
hours following a single
application.
4/12/

Summary of Product characteristics

PRODUCT NAME: OPTICLOX EYE OINTMENT
PAGE: 1 OF 4
THIS REVISION ISSUED: SEPTEMBER, 2009
MATERIAL SAFETY DATA SHEET
Issued by: Norbrook Laboratories Australia Pty Ltd
Freecall: 1800 665 866
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
NORBROOK LABORATORIES AUSTRALIA PTY LTD
FREECALL: 1800 665 866
UNIT 7/1 TRADE PARK DRIVE
TULLAMARINE, VIC 3043 AUSTRALIA
SUBSTANCE:
Cloxacillin is a semi-synthetic penicillin derived from 6-amino-
penicillanic acid.
TRADE NAME:
OPTICLOX EYE OINTMENT
APVMA CODE:
50938
PRODUCT USE:
For the treatment of bovine keratoconjunctivitis where cloxacillin
susceptible bacteria
(including _Moraxella bovis_) are suspected or anticipated as
pathogens. Also for the
treatment of bacterial keratoconjunctivitis caused by
cloxacillin-susceptible bacteria in
sheep, horses, dogs and cats.
CREATION DATE:
SEPTEMBER, 2009
THIS VERSION ISSUED:
SEPTEMBER, 2009
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S36. Wear suitable protective clothing.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Smooth sterile cream coloured, cream.
ODOUR:
Odourless.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may
cause sensitisation. This is a physiologically active product and so
contact should be minimised, especially if the user
is taking a form of medication, as interactions can sometimes give
unexpected and undesi